Biochemical fractionation and purification of high-molecular-mass APOBEC3G complexes

Methods in Molecular Biology

Volumn 718, Issue , 2011, Pages 185-206

  Chiu, Ya Lin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alu; APOBEC3G; Cytidine deaminases; FPLC; High molecular mass; HIV 1; Low molecular mass; Retrotransposition; Tandem affinity purification; Vif

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; MULTIPROTEIN COMPLEX; VIRAL PROTEIN; APOBEC3G PROTEIN, HUMAN; CYTIDINE DEAMINASE;

BIOCHEMICAL ANALYSIS; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL ISOLATION; CELL LYSATE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; FAST PROTEIN LIQUID CHROMATOGRAPHY; FRACTIONATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; MAGNETIC FIELD; MOLECULAR WEIGHT; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN RNA BINDING; PURIFICATION; VIRION; VIRUS ENTRY; VIRUS INFECTIVITY; WESTERN BLOTTING; AFFINITY CHROMATOGRAPHY; ARTICLE; CELL CULTURE; CELL SEPARATION; GENETIC TRANSFECTION; ISOLATION AND PURIFICATION; LIQUID CHROMATOGRAPHY; METHODOLOGY;

BLOTTING, WESTERN; CELL SEPARATION; CELLS, CULTURED; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, LIQUID; CYTIDINE DEAMINASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; TRANSFECTION;

EID: 84855509259     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-018-8_12     Document Type: Chapter

References (43)

1. Sheehy, A. M., Gaddis, N. C., Choi, J. D., and Malim, M. H. (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650.
2. Chiu, Y. L. and Greene, W. C. (2008) The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol 26, 317-353.
3. Soros, V. B., Yonemoto, W., and Greene, W. C. (2007) Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H. PLoS Pathog 3, e15.
4. Bishop, K. N., Verma, M., Kim, E. Y., Wolinsky, S. M., and Malim, M. H. (2008) APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog 4, e1000231.
5. Guo, F., Cen, S., Niu, M., Saadatmand, J., and Kleiman, L. (2006) Inhibition of formulaprimed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication. J Virol 80, 11710-11722.
6. Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., and Trono, D. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103.
7. Lecossier, D., Bouchonnet, F., Clavel, F., and Hance, A. J. (2003) Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300, 1112.
8. Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., and Malim, M. H. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803-809.
9. Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., and Gao, L. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94-98.
10. Mbisa, J. L., Barr, R., Thomas, J. A., Vandegraaff, N., Dorweiler, I. J., Svarovskaia, E. S., Brown, W. L., Mansky, L. M., Gorelick, R. J., Harris, R. S., Engelman, A., and Pathak, V. K. (2007) HIV-1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. J Virol 81, 7099-7110.
11. Luo, K., Wang, T., Liu, B., Tian, C., Xiao, Z., Kappes, J., and Yu, X. F. (2007) Cytidine deaminases APOBEC3G and APOBEC3F interact with HIV-1 integrase and inhibit proviral DNA formation. J Virol 81, 7238-7248.
12. Stopak, K., de Noronha, C., Yonemoto, W., and Greene, W. C. (2003) HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell 12, 591-601.
13. Conticello, S. G., Harris, R. S., and Neuberger, M. S. (2003) The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr Biol 13, 2009-2013.
14. Marin, M., Rose, K. M., Kozak, S. L., and Kabat, D. (2003) HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 9, 1398-1403.
15. Sheehy, A. M., Gaddis, N. C., and Malim, M. H. (2003) The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9, 1404-1407.
16. Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., and Yu, X. F. (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060.
17. Mariani, R., Chen, D., Schrofelbauer, B., Navarro, F., Konig, R., Bollman, B., Munk, C., Nymark-McMahon, H., and Landau, N. R. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114, 21-31.
18. Chiu, Y. L., Soros, V. B., Kreisberg, J. F., Stopak, K., Yonemoto, W., and Greene, W. C. (2005) Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435, 108-114.
19. Kreisberg, J. F., Yonemoto, W., and Greene, W. C. (2006) Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J Exp Med 203, 865-870.
20. Stopak, K. S., Chiu, Y. L., Kropp, J., Grant, R. M., and Greene, W. C. (2007) Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J Biol Chem 282, 3539-3546.
21. Ellery, P. J., Tippett, E., Chiu, Y. L., Paukovics, G., Cameron, P. U., Solomon, A., Lewin, S. R., Gorry, P. R., Jaworowski, A., Greene, W. C., Sonza, S., and Crowe, S. M. (2007) The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol 178, 6581-6589.
22. Pion, M., Granelli-Piperno, A., Mangeat, B., Stalder, R., Correa, R., Steinman, R. M., and Piguet, V. (2006) APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J Exp Med 203, 2887-2893.
23. Wang, F. X., Huang, J., Zhang, H., and Ma, X. (2008) APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells. J Gen Virol 89, 722-730.
24. Kamata, M., Nagaoka, Y., and Chen, I. S. (2009) Reassessing the role of APOBEC3G in human immunodeficiency virus type 1 infection of quiescent CD4+ T-cells. PLoS Pathog 5, e1000342.
25. Santoni de Sio, F. R. and Trono, D. (2009) APOBEC3G-depleted resting CD4+ T cells remain refractory to HIV1 infection. PLoS One 4, e6571.
26. Chen, K., Huang, J., Zhang, C., Huang, S., Nunnari, G., Wang, F. X., Tong, X., Gao, L., Nikisher, K., and Zhang, H. (2006) Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells. J Virol 80, 7645-7657.
27. Vetter, M. L. and D’Aquila, R. T. (2009) Cytoplasmic APOBEC3G restricts incoming Vif-positive HIV-1 and increases 2-LTR circle formation in activated T helper subtype cells. J Virol 83, 8646-8654.
28. Lafferty, M. K., Sun, L., Demasi, L., Lu, W., and Garzino-Demo, A. CCR6 ligands inhibit HIV by inducing APOBEC3G. Blood 115, 1564-1571.
29. Chiu, Y. L., Witkowska, H. E., Hall, S. C., Santiago, M., Soros, V. B., Esnault, C., Heidmann, T., and Greene, W. C. (2006) High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc Natl Acad Sci USA 103, 15588-15593.
30. Gallois-Montbrun, S., Kramer, B., Swanson, C. M., Byers, H., Lynham, S., Ward, M., and Malim, M. H. (2007) Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J Virol 81, 2165-2178.
31. Kozak, S. L., Marin, M., Rose, K. M., Bystrom, C., and Kabat, D. (2006) The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J Biol Chem 281, 29105-29119.
32. Wichroski, M. J., Robb, G. B., and Rana, T. M. (2006) Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies. PLoS Pathog 2, e41.
33. Huang, J., Liang, Z., Yang, B., Tian, H., Ma, J., and Zhang, H. (2007) Derepression of microRNA-mediated protein translation inhibition by apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members. J Biol Chem 282, 33632-33640.
34. Dewannieux, M., Esnault, C., and Heidmann, T. (2003) LINE-mediated retrotransposition of marked Alu sequences. Nat Genet 35, 41-48.
35. Kazazian, H. H. J. (2004) Mobile elements: drivers of genome evolution. Science 303, 1626-1632.
36. Hulme, A. E., Bogerd, H. P., Cullen, B. R., and Moran, J. V. (2007) Selective inhibition of Alu retrotransposition by APOBEC3G. Gene 390, 199-205.
37. Boyum, A. (1968) Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 97, 77-89.
38. Bain, B. and Pshyk, K. (1972) Enhanced reactivity in mixed leukocyte cultures after separation of mononuclear cells on Ficoll-Hypaque. Transplant Proc 4, 163-164.
39. Rigaut, G., Shevchenko, A., Rutz, B., Wilm, M., Mann, M., and Seraphin, B. (1999) A generic protein purification method for protein complex characterization and proteome exploration. Nat Biotechnol 17, 1030-1032.
40. Puig, O., Caspary, F., Rigaut, G., Rutz, B., Bouveret, E., Bragado-Nilsson, E., Wilm, M., and Seraphin, B. (2001) The tandem affinity purification (TAP) method: a general procedure of protein complex purification. Methods 24, 218-229.
41. Wilson, D. S., Keefe, A. D., and Szostak, J. W. (2001) The use of mRNA display to select high-affinity protein-binding peptides. Proc Natl Acad Sci USA 98, 3750-3755.
42. Keefe, A. D., Wilson, D. S., Seelig, B., and Szostak, J. W. (2001) One-step purification of recombinant proteins using a nanomolaraffinity streptavidin-binding peptide, the SBPTag. Protein Expr Purif 23, 440-446.
43. Stofko-Hahn, R. E., Carr, D. W., and Scott, J. D. (1992) A single step purification for recombinant proteins. Characterization of a microtubule associated protein (MAP 2) fragment which associates with the type II cAMP-dependent protein kinase. FEBS Lett 302, 274-278.